Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Historical Holders from Q1 2018 to Q2 2025

Symbol
SLDB on Nasdaq
CUSIP
83422E105
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
79.2M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
733
Holdings value
$3.57K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
3
Number of buys
3
Number of sells
-1
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $32M 7.99M RA Capital Management, L.P. Feb 19, 2025
BCLS SB Investco, LP 7.8% $2.11M 6.18M BCLS II Investco, LP Feb 19, 2025

Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 733 $3.57K +$1.35K $4.87 3
2025 Q1 478 $1.77K +$1.74K $3.71 3
2024 Q4 7 $28.00 $4.00 1
2024 Q3 7 $49.00 $0 $7.00 1
2024 Q2 7 $40.00 +$6.00 $5.71 1
2024 Q1 6 $80.00 $0 $13.33 1
2023 Q4 6 $37.00 $0 $6.17 1
2023 Q3 6 $15.00 -$346 $2.50 1
2023 Q2 72 $377 $0 $5.20 2
2023 Q1 72 $341 -$57.8K $4.70 2
2022 Q4 10.8K $58.1K -$29.1M $5.36 2
2022 Q3 62.9M $29.2M +$803K $0.47 47
2022 Q2 64.2M $39.5M -$5.53M $0.62 55
2022 Q1 69.2M $83M -$7.76M $1.20 70
2021 Q4 69.3M $121M -$8.13M $1.75 76
2021 Q3 76.9M $184M -$9.19M $2.39 86
2021 Q2 75.4M $276M -$5.73M $3.66 87
2021 Q1 79.1M $438M +$126M $5.53 103
2020 Q4 50.8M $385M +$229M $7.58 71
2020 Q3 25.4M $51.6M -$3.17M $2.03 54
2020 Q2 24.4M $71.5M +$20.1M $2.93 63
2020 Q1 18.8M $44.8M -$1.35M $2.39 68
2019 Q4 19.8M $88.1M -$124M $4.45 64
2019 Q3 32.1M $332M +$115M $10.34 68
2019 Q2 18M $103M +$19.7M $5.75 69
2019 Q1 16.7M $154M -$217M $9.20 72
2018 Q4 24.2M $648M +$129M $26.80 73
2018 Q3 18.6M $878M +$64.7M $47.18 76
2018 Q2 15.3M $545M +$93.3M $35.63 62
2018 Q1 15.6M $117M +$117M $7.50 55